Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

A rational vaccine pipeline for tuberculosis.

Brennan MJ, Stone MR, Evans T.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1566-73. doi: 10.5588/ijtld.12.0569. Review.

PMID:
23131253
2.

TB vaccines for the World.

Glyn Hewinson R.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):1-6. Epub 2005 Jan 17.

PMID:
15687020
3.

The tuberculosis vaccine challenge.

Brennan MJ.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):7-12. Review.

PMID:
15687021
4.

Novel tuberculosis vaccines on the horizon.

Parida SK, Kaufmann SH.

Curr Opin Immunol. 2010 Jun;22(3):374-84. doi: 10.1016/j.coi.2010.04.006. Epub 2010 May 12. Review.

PMID:
20471231
5.

Key issues in the clinical development and implementation of TB vaccines in South Africa.

Rustomjee R, Mcleod R, Hanekom W, Steel G, Mahomed H, Hawkridge A, Welte A, Sinanovic E, Loots G, Grobler A, Mvusi L, Gray G, Hesseling A, Ginsberg A, Lienhardt C, Shea J, Tong X, Lockhart S, Churchyard GJ.

Tuberculosis (Edinb). 2012 Sep;92(5):359-64. doi: 10.1016/j.tube.2012.05.001. Epub 2012 Jun 12.

PMID:
22698868
6.

New vaccines against tuberculosis.

Mark Doherty T.

Trop Med Int Health. 2004 Jul;9(7):818-26. Review.

7.

Antituberculous vaccine development: a perspective for the endemic world.

Verma I, Grover A.

Expert Rev Vaccines. 2009 Nov;8(11):1547-53. doi: 10.1586/erv.09.111. Review.

PMID:
19863247
8.

Tuberculosis vaccine development: research, regulatory and clinical strategies.

Brennan MJ, Morris SL, Sizemore CF.

Expert Opin Biol Ther. 2004 Sep;4(9):1493-504. Review.

PMID:
15335316
9.

Vaccines against tuberculosis: where are we and where do we need to go?

Ottenhoff TH, Kaufmann SH.

PLoS Pathog. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.1002607. Epub 2012 May 10. Review.

10.

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Dietrich J, Doherty TM.

APMIS. 2009 May;117(5-6):440-57. doi: 10.1111/j.1600-0463.2009.02458.x. Review.

PMID:
19400867
11.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
12.

First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.

Ottenhoff TH, Doherty TM, van Dissel JT, Bang P, Lingnau K, Kromann I, Andersen P.

Hum Vaccin. 2010 Dec;6(12):1007-15. Epub 2010 Dec 1. Review.

PMID:
21178394
13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
14.

Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccination.

Orme IM.

Tuberculosis (Edinb). 2006 Jan;86(1):68-73. Epub 2005 Nov 2.

PMID:
16260181
15.

Development of vaccines against tuberculosis.

Tyagi AK, Nangpal P, Satchidanandam V.

Tuberculosis (Edinb). 2011 Sep;91(5):469-78. doi: 10.1016/j.tube.2011.01.003. Epub 2011 Feb 18. Review.

PMID:
21334259
16.

Tuberculosis vaccine research: the impact of immunology.

Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.

Curr Opin Immunol. 2009 Jun;21(3):331-8. doi: 10.1016/j.coi.2009.05.017. Epub 2009 Jun 7. Review.

PMID:
19505813
17.

Clinical studies of TB vaccines.

Hawkridge A.

Hum Vaccin. 2009 Nov;5(11):773-6. Epub 2009 Nov 22. Review.

PMID:
19684467
18.

New tuberculosis vaccines.

Martín Montañés C, Gicquel B.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:57-62. doi: 10.1016/S0213-005X(11)70019-2. Review.

PMID:
21420568
19.

Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.

Sierra VG.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):169-78. Review.

PMID:
16677860
20.

The search for a tuberculosis vaccine: an elusive quest?

Nagelkerke NJ, de Vlas SJ, Mahendradhata Y, Ottenhoff TH, Borgdorff M.

Tuberculosis (Edinb). 2006 Jan;86(1):41-6. Epub 2005 Oct 25. Review.

PMID:
16253559

Supplemental Content

Support Center